– USA, FL – Inspira Financial Inc. (TSX:LND) today announced the appointment of Randy Berholtz, JD, MBA, to the board of directors of the Company.
He will be replacing David Forstadt on the board, who is stepping down.
“We are excited to have Randy join the board at Inspira, as we seek to identify profitable transactions for our shareholders,” said Dr. Jaime Gerber, Interim CEO and Chairman of Inspira. “Randy’s extensive experience operating and investing in healthcare and life science companies is the kind of experience that Inspira needs moving forward. His skill set as a venture capitalist, corporate development and legal professional, complements our existing board composition and will help Inspira expand on its current corporate strategy.”
Dr. Gerber continued: “I would also like to thank Mr. Forstadt for his work as a member of the board of directors, it has been a pleasure working with him here at Inspira and we wish him luck on his future ventures.”
About Randy Berholtz
Mr. Berholtz is the Senior Fund Advisor and Fund Counsel for Mesa Verde Venture Partners in San Diego, California, where he is also a Member of the Investment Committee. Mr. Berholtz has over 24 years of experience in mergers and acquisitions, securities, private and public financing and venture capital. Additionally, for the last 14 years he has served as the general counsel for three public life science companies and served on the board of directors of several successful startup companies in the life sciences and health related fields, namely Nanogen, Inc., Apricus Biosciences, Inc., and Innovus Pharmaceuticals, Inc.
For more information : http://www.inspirafin.ca
- Disclaimer - News, data, and statements included in this release are intended exclusively for general information purposes. Talent4Boards does not guarantee that news is accurate or about the correct person and accepts neither liability for the consequences of the reader’s reliance, nor responsibility for the accuracy of the information. Nothing in this release should be considered for decisions about referred securities. Products and brand names may be trademarks or registered trademarks of their respective owners.
